Despite Aaron's Company's limited growth expectations, investors are still willing to pay for exposure to the stock. However, the company's current P/S ratio may be at risk of declining unless there is a positive change in its revenue outlook.
Trader-101スレ主curtaincall:
some time's but if you know stocks the way that I do it's the best way to get a good buy on a great stock you always buy when there's blood in the water and then you just wait it out
Trader-101スレ主curtaincall:
Believe it or not AAN is probably in the top 20% of the best ranked stocks and that's why I pay attention to secondary offering or lock out expirations so that I can snatch up a few stocks that I would never be able to buy at such a good entry you have to think about long term I only day trade with 20,%of my holdings
Trader-101スレ主curtaincall:
And the way that I picked that up I heard one of the best investors of our time said at a conference name of Warren Buffett from Berkshire Hathaway
アーロンズに関するコメント
In reaction to earnings/guidance:
• $コムテック テレコミュニケーションズ(CMTL.US)$ +2.1%, $マイクロン テクノロジー(MU.US)$+1.5%
Other news:
• $アミリックス ファーマシューティカルズ(AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $レディ・キャピタル(RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron(APRN.US)$ +2.5% (CFO to resign)
• $フルアー(FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $イミュニアリング A(IMRX.US)$ +1.6% (re...
In reaction to earnings/guidance:
$リバティ エナジー A(LBRT.US)$ +11.6%, $F5 インク(FFIV.US)$ +6.9%, $エンコア ワイヤ(WIRE.US)$ + 5.6%, $アーチャー ダニエルズ ミッドランド(ADM.US)$ +5.5%, $バンク オブ エヌティー バターフィールド&サン(NTB.US)$ +5%, $アルバニー インターナショナル A(AIN.US)$ +5%, $スリーエム(MMM.US)$ +4.0%,
Other news:
$Shell Midstream(SHLX.US)$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$ブリッジバイオ ファーマ(BBIO.US)$...
Sometimes I like to go through the biggest losers of the day and pick out the diamonds in the rough I just had a bad day.
$アーロンズ(AAN.US)$ diamond in the rough
$Baudax Bio Inc(BXRX.US)$
$エスペリオン セラピューティクス(ESPR.US)$
$Proteostasis Therapeutics Inc(PTI.US)$
まだコメントはありません